Efficacy of Compound Kushen Injection in Combination with Induction Chemotherapy for Treating Adult Patients Newly Diagnosed with Acute Leukemia
Table 2
Comparison of immune function indices and cytokines in the treatment and control groups before and after treatment ().
Variable
Treatment group ()
Control group ()
Before treatment
After treatment
Before treatment
After treatment
CD3+
56.43 ± 4.22
55.45 ± 4.22
55.38 ± 5.33
34.29 ± 4.93
CD4+
31.55 ± 5.33
35.35 ± 4.24
33.19 ± 5.39
17.13 ± 5.81
CD8+
13.32 ± 2.33
13.12 ± 2.23
14.31 ± 3.02
15.23 ± 3.03
CD4+/CD8+
1.69 ± 0.33
1.73 ± 0.22
1.68 ± 0.42
1.08 ± 0.33
NK cells
15.44 ± 3.35
15.41 ± 4.02
15.12 ± 3.72
10.12 ± 3.11
IgG
12.5 ± 1.3
12.3 ± 1.2
12.4 ± 1.3
7.2 ± 1.5
IgA
2.4 ± 0.3
2.3 ± 0.3
2.4 ± 0.3
1.2 ± 0.5
IgM
1.71 ± 0.30
1.58 ± 0.4
1.81 ± 0.47
0.45 ± 0.53
IL-4
20.0 ± 2.4
22.2 ± 2.3
22.5 ± 3.2
11.8 ± 2.2
IL-10
17.10 ± 2.2
19.4 ± 4.2
18.90 ± 2.1
9.80 ± 3.2
Notes: compared with the control group after treatment, ; compared with the treatment group before treatment, ; compared with the control group before treatment, .
